Kenneth M. Williams


Recent developments in targeting access to high cost medicines in Australia

The Pharmaceutical Benefits Scheme has developed a set of arrangements to control access to high-cost medicines, including tumour necrosis factor-alpha inhibitors (TNFIs) for the treatment of rheumatoid arthritis. In this article Christine Y. Lu, Jan Ritchie, Kenneth M. Williams and Richard O. Day explore basic...